Speaker Profile
Other, Product Strategy and Commercialization, Mithrl
Biography
Naomi Thomson works in Product Strategy and Commercialization at Mithrl, where we focus on translating AI-enabled analytics into practical, reproducible tools for biological discovery. She brings more than 30 years of experience working with molecular data across academic and industry settings, with deep expertise in next-generation sequencing, transcriptomics, and integrative data analysis.
Talk
From Analysis to Insight: AI as Co-Scientist
Advances in AI promise faster discovery, yet value depends on how scientists collaborate. This talk introduces Mithrl as a co-scientist designed to bridge biological and computational perspectives. Using published arthritis and human heart organoid studies, we illustrate how AI-mediated interpretation improves communication, confidence, and insight without compromising reproducibility and transparency.
AI and Data Sciences Showcase:
Mithrl
Mithrl serves pharma and biotech researchers as an AI Co-Scientist, turning raw omics and other data into new candidates for biomarkers, targets, and other new hypotheses in minutes. Discovery and preclinical teams interact with Mithrl in natural language, bridging biologists and computational teams to uncover insights faster, gain a discovery edge, and move therapies from idea to patient more quickly.
Session Abstract – PMWC 2026 Silicon Valley
The PMWC 2026 AI Company Showcase will provide a 15-30 minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.
